SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-17-062780
Filing Date
2017-10-18
Accepted
2017-10-18 17:11:33
Documents
1
Period of Report
2017-10-12

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 9617
  Complete submission text file 0001104659-17-062780.txt   11733
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Issuer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WFD VENTURES LLC 1500 BROADWAY, 17TH FLOOR NEW YORK NY 10036
Business Address C/O WFD VENTURES LLC 1500 BROADWAY, 17TH FLOOR NEW YORK NY 10036 212-767-7500
TKWD Ventures LLC (Reporting) CIK: 0001719928 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38241 | Film No.: 171143131

Mailing Address 1500 BROADWAY, 17TH FLOOR NEW YORK NY 10036
Business Address 1500 BROADWAY, 17TH FLOOR NEW YORK NY 10036 212-767-7500
WFD Ventures LLC (Reporting) CIK: 0001720002 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38241 | Film No.: 171143132